Description
The clinical assessment of metabolic health involves a multidimensional approach that goes beyond measuring blood glucose alone. Core tools include waist circumference, blood pressure, fasting glucose, lipid profile (triglycerides and HDL), and HbA1c, with advanced markers like fasting insulin, HOMA-IR, and liver enzymes (ALT, AST) offering deeper insight into insulin resistance and fatty liver risk. Subtle red flags—such as normal glucose with high insulin, abdominal obesity despite normal BMI, acanthosis nigricans, or elevated triglyceride-to-HDL ratios—may indicate early metabolic dysfunction. Lifestyle factors like diet, sleep, stress, and physical activity, along with family history, are essential in forming a complete risk profile. Recognizing these early signs enables timely intervention through lifestyle and clinical management, helping prevent progression to chronic diseases like type 2 diabetes, cardiovascular conditions, and NAFLD.
Summary Listen
- Dr. Benita's presentation focused on the evolving concept of metabolic health, highlighting its progression from the initial focus on insulin resistance and cardiovascular disease risk to the broader understanding encompassing multiple organ systems. She emphasized that while metabolic syndrome, defined by central obesity, blood pressure, and impaired glucose metabolism, remains relevant, a more comprehensive approach is necessary.
- She proposed the "ABCs" for initial metabolic health assessment: HBA1c/sugar levels, blood pressure, and BMI. She stressed the importance of LDL cholesterol, often overlooked in metabolic syndrome definitions, as a crucial indicator of cardiovascular health. The presentation also highlighted the need to consider liver, kidney, and thyroid function, as well as basic nutritional assessments, in a comprehensive evaluation.
- She addressed the evolving understanding of Non-Alcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD). The MAFLD diagnosis emphasizes the inclusion of metabolic risk factors and highlighted the importance of identifying liver fibrosis using tools like the FIB-4 score. Lifestyle interventions, including weight loss, diet, and exercise, remain the cornerstone of MAFLD management.
- The presentation delved into the "crosstalk" between organ systems in metabolic health, particularly emphasizing the roles of muscle and gut health. Low muscle mass (sarcopenia) and impaired muscle function were identified as important metabolic parameters. The significance of cardiorespiratory fitness and formal assessments of muscle mass, muscle function, and aerobic capacity were emphasized.
- She addressed the emerging role of gut microbiome in metabolic health. While acknowledging ongoing research and potential therapeutic targets, she cited a consensus statement cautioning against the premature use of gut microbiome testing in clinical practice. She also provided resources for understanding probiotics, prebiotics, and their potential benefits.
- She concluded by summarizing key components of preventive health checkups, highlighting "red flags" such as significantly elevated blood pressure, BMI, HBA1c, LDL, triglycerides, and abnormal kidney function. She touched upon the increasing interest in longevity and biological age assessments, indicating future areas for discussion and research. She ended by addressing the question of optimum exercise and the potential negative impacts of extreme exercise on heart health.
Sample Certificate
About the Speakers
Dr. Binita Priyambada
Medical Director, Even Healthcare, Bengaluru
Comments
Comments
You must be logged in to leave a comment.